Why is COSMOS Pharmaceutical Corp. ?
1
Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 12.99%
- Healthy long term growth as Net Sales has grown by an annual rate of 8.92%
- Company has very low debt and has enough cash to service the debt requirements
2
The company has declared Negative results for the last 4 consecutive quarters
- DEBT-EQUITY RATIO (HY) Highest at -2.75 %
- INTEREST COVERAGE RATIO(Q) Lowest at 13,567.89
- DEBTORS TURNOVER RATIO(HY) Lowest at 82.77%
3
With ROE of 12.06%, it has a expensive valuation with a 2.83 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 7.13%, its profits have risen by 21%
4
Underperformed the market in the last 1 year
- The stock has generated a return of 7.13% in the last 1 year, much lower than market (Japan Nikkei 225) returns of 28.54%
How much should you hold?
- Overall Portfolio exposure to COSMOS Pharmaceutical Corp. should be less than 10%
- Overall Portfolio exposure to Retailing should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Retailing)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is COSMOS Pharmaceutical Corp. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
COSMOS Pharmaceutical Corp.
7.13%
0.54
29.17%
Japan Nikkei 225
28.54%
1.11
25.75%
Quality key factors
Factor
Value
Sales Growth (5y)
8.92%
EBIT Growth (5y)
8.51%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
0.02
Sales to Capital Employed (avg)
3.72
Tax Ratio
26.89%
Dividend Payout Ratio
17.91%
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
18.81%
ROE (avg)
12.99%
Valuation Key Factors 
Factor
Value
P/E Ratio
23
Industry P/E
Price to Book Value
2.83
EV to EBIT
18.00
EV to EBITDA
11.62
EV to Capital Employed
2.78
EV to Sales
0.71
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
15.47%
ROE (Latest)
12.06%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bearish
No Trend
Technical Movement
7What is working for the Company
ROCE(HY)
Highest at 12.67%
DIVIDEND PAYOUT RATIO(Y)
Highest at 34.42%
RAW MATERIAL COST(Y)
Fallen by -7.52% (YoY
DIVIDEND PER SHARE(HY)
Highest at JPY 82.77
NET PROFIT(Q)
Highest at JPY 8,705.5 MM
EPS(Q)
Highest at JPY 108.95
-16What is not working for the Company
DEBT-EQUITY RATIO
(HY)
Highest at -2.75 %
INTEREST COVERAGE RATIO(Q)
Lowest at 13,567.89
DEBTORS TURNOVER RATIO(HY)
Lowest at 82.77%
INTEREST(Q)
Highest at JPY 109 MM
Here's what is working for COSMOS Pharmaceutical Corp.
Net Profit
Highest at JPY 8,705.5 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (JPY MM)
EPS
Highest at JPY 108.95
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (JPY)
Dividend per share
Highest at JPY 82.77
in the last five yearsMOJO Watch
Company is distributing higher dividend from profits generated
DPS (JPY)
Dividend Payout Ratio
Highest at 34.42%
in the last five yearsMOJO Watch
Company is distributing higher proportion of profits generated as dividend
DPR (%)
Raw Material Cost
Fallen by -7.52% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at JPY 6,013 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (JPY MM)
Here's what is not working for COSMOS Pharmaceutical Corp.
Interest
At JPY 109 MM has Grown at 127.08%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (JPY MM)
Interest Coverage Ratio
Lowest at 13,567.89
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Debt-Equity Ratio
Highest at -2.75 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Interest
Highest at JPY 109 MM
in the last five periods and Increased by 127.08% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (JPY MM)
Debtors Turnover Ratio
Lowest at 82.77%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio






